262 related articles for article (PubMed ID: 26132930)
1. The Emerging Role of Chronic Low-Grade Inflammation in the Pathophysiology of Polycystic Ovary Syndrome.
Shorakae S; Teede H; de Courten B; Lambert G; Boyle J; Moran LJ
Semin Reprod Med; 2015 Jul; 33(4):257-69. PubMed ID: 26132930
[TBL] [Abstract][Full Text] [Related]
2. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
[TBL] [Abstract][Full Text] [Related]
3. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
5. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
Rosenfield RL; Ehrmann DA
Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
[TBL] [Abstract][Full Text] [Related]
6. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
González F
Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome and type 2 diabetes mellitus.
De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
[TBL] [Abstract][Full Text] [Related]
8. Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.
Sozen I; Arici A
Obstet Gynecol Surv; 2000 May; 55(5):321-8. PubMed ID: 10804539
[TBL] [Abstract][Full Text] [Related]
9. Chronic Low Grade Inflammation in Pathogenesis of PCOS.
Rudnicka E; Suchta K; Grymowicz M; Calik-Ksepka A; Smolarczyk K; Duszewska AM; Smolarczyk R; Meczekalski B
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917519
[TBL] [Abstract][Full Text] [Related]
10. The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome.
Barber TM; Vojtechova P; Franks S
Horm Mol Biol Clin Investig; 2013 Sep; 15(3):91-103. PubMed ID: 25436736
[TBL] [Abstract][Full Text] [Related]
11. Abdominal adiposity and the polycystic ovary syndrome.
Escobar-Morreale HF; San Millán JL
Trends Endocrinol Metab; 2007 Sep; 18(7):266-72. PubMed ID: 17693095
[TBL] [Abstract][Full Text] [Related]
12. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome.
Wang J; Wu D; Guo H; Li M
Life Sci; 2019 Nov; 236():116940. PubMed ID: 31604107
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome.
Nandi A; Chen Z; Patel R; Poretsky L
Endocrinol Metab Clin North Am; 2014 Mar; 43(1):123-47. PubMed ID: 24582095
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in PCOS.
Diamanti-Kandarakis E
Endocrine; 2006 Aug; 30(1):13-7. PubMed ID: 17185787
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk in women with polycystic ovary syndrome.
Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
[TBL] [Abstract][Full Text] [Related]
16. Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review.
Carvalho LML; Dos Reis FM; Candido AL; Nunes FFC; Ferreira CN; Gomes KB
Endocr Regul; 2018 Oct; 52(4):208-221. PubMed ID: 31517612
[TBL] [Abstract][Full Text] [Related]
17. Role of obesity and adiposity in polycystic ovary syndrome.
Diamanti-Kandarakis E
Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
[TBL] [Abstract][Full Text] [Related]
18. The role of low-grade inflammation in the polycystic ovary syndrome.
Repaci A; Gambineri A; Pasquali R
Mol Cell Endocrinol; 2011 Mar; 335(1):30-41. PubMed ID: 20708064
[TBL] [Abstract][Full Text] [Related]
19. The interplay between androgens and the immune response in polycystic ovary syndrome.
Shabbir S; Khurram E; Moorthi VS; Eissa YTH; Kamal MA; Butler AE
J Transl Med; 2023 Apr; 21(1):259. PubMed ID: 37062827
[TBL] [Abstract][Full Text] [Related]
20. [Insulin resistance in the pathogenesis of polycystic ovarian disease (PCOD)].
Jakowicki J
Ginekol Pol; 1994 Oct; 65(10):582-6. PubMed ID: 7729720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
